menu
    • menu

    Company profile for BIOQUAL

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BIOQUAL was established in 1981, and performs contract research services focused on in vivo models of human diseases including COVID-19, AIDS, influenza, RSV infection, Flavivirus infections including Zika and Dengue, malaria, hepatitis, and cancer. BIOQUAL has laboratories and vivariums under both BSL-2 and BSL-3 containment. In addition, BIOQUAL maintains CDC-approved BSL-3 containment laboratories for studies associated wit...
    BIOQUAL was established in 1981, and performs contract research services focused on in vivo models of human diseases including COVID-19, AIDS, influenza, RSV infection, Flavivirus infections including Zika and Dengue, malaria, hepatitis, and cancer. BIOQUAL has laboratories and vivariums under both BSL-2 and BSL-3 containment. In addition, BIOQUAL maintains CDC-approved BSL-3 containment laboratories for studies associated with Select Agents including highly pathogenic avian influenza. BIOQUAL’s laboratories are actively involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BIOQUALUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9600 Medical Center Drive Suite 101 Rockville, MD 20850-3336
    Telephone
    Telephone
    800-208-3149
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bioqual.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/bioqual-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BIOQUAL Unveils Q2 Fiscal Year 2026 Financial Results
    BIOQUAL Unveils Q2 Fiscal Year 2026 Financial Results

    22 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260122375204/en/BIOQUAL-Presents-Unaudited-Financial-Results-for-Second-Quarter-of-Fiscal-Year-2026

    BUSINESSWIRE
    22 Jan 2026
    Share Share
    BIOQUAL Unveils Q1 Fiscal 2026 Financial Results
    BIOQUAL Unveils Q1 Fiscal 2026 Financial Results

    21 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251021281728/en/BIOQUAL-Presents-Unaudited-Financial-Results-for-First-Quarter-of-Fiscal-Year-2026

    BUSINESSWIRE
    21 Oct 2025
    Share Share
    BIOQUAL Unveils Fiscal Year 2025 Financial Results
    BIOQUAL Unveils Fiscal Year 2025 Financial Results

    19 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250919294179/en/BIOQUAL-Presents-Financial-Results-for-Fiscal-Year-2025

    BUSINESSWIRE
    19 Sep 2025
    Share Share
    Bioqual announces retirement of Dr. Mark G. Lewis as President & CEO
    Bioqual announces retirement of Dr. Mark G. Lewis as President & CEO

    30 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250430468044/en/BIOQUAL-Announces-the-retirement-of-Dr.-Mark-G.-Lewis-as-President-and-CEO-of-the-company

    BUSINESSWIRE
    30 Apr 2025
    Share Share
    BIOQUAL Announces Retirement of Mike O'Flaherty From Board
    BIOQUAL Announces Retirement of Mike O'Flaherty From Board

    24 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250424459366/en/BIOQUAL-Announces-Retirement-of-Mike-OFlaherty-From-Board

    BUSINESSWIRE
    24 Apr 2025
    Share Share
    Bioqual Unveils Q3 Fiscal Year 2025 Financial Results
    Bioqual Unveils Q3 Fiscal Year 2025 Financial Results

    11 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250411471321/en/BIOQUAL-Presents-Unaudited-Financial-Results-for-Third-Quarter-of-Fiscal-Year-2025

    BUSINESSWIRE
    11 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search